Literature DB >> 15178475

Yessotoxin, a shellfish biotoxin, is a potent inducer of the permeability transition in isolated mitochondria and intact cells.

Cristina Bianchi1, Romana Fato, Alessia Angelin, Fabiana Trombetti, Vittoria Ventrella, Anna Rosa Borgatti, Ernesto Fattorusso, Patrizia Ciminiello, Paolo Bernardi, Giorgio Lenaz, Giovanna Parenti Castelli.   

Abstract

The diarrhetic poisoning by bivalve molluscs, diarrhetic shellfish poisoning, is due to consumption of mussels containing biotoxins produced by some Dinoflagellate species. Toxic effects of yessotoxin (YTX) include morphological alterations of mitochondria from heart and liver but the biochemical basis for these alterations is completely unknown. This paper demonstrates that YTX is a very powerful compound that opens the permeability transition pore (PTP) of the inner mitochondrial membrane of rat liver mitochondria at nanomolar concentrations. The effect requires the presence of a permissive level of calcium, by itself incapable of opening the pore. The direct effect of YTX on PTP is further confirmed by the inhibition exerted by cyclosporin A (CsA) that is known as a powerful inhibitor of PTP opening. Moreover, YTX induces membrane depolarization as shown by the quenching of tetramethylrhodamine methyl ester (TMRM), also prevented by the addition of CsA. YTX caused PTP opening in Morris Hepatoma 1C1 cells, as shown by the occurrence of CsA-sensitive depolarization within minutes of the addition of submicromolar concentrations of the toxin. These results provide a biochemical basis for the mitochondrial alterations observed in the course of intoxication with YTX, offering the first clue into the pathogenesis of diseases caused by YTX, and providing a novel tool to study the PTP in situ.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178475     DOI: 10.1016/j.bbabio.2004.02.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle.

Authors:  Jolanta Skalska; Grazyna Debska; Wolfram S Kunz; Adam Szewczyk
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

2.  Heat exposure does not alter eccentric exercise-induced increases in mitochondrial calcium and respiratory dysfunction.

Authors:  Ben Rattray; C Caillaud; P A Ruell; M W Thompson
Journal:  Eur J Appl Physiol       Date:  2011-03-18       Impact factor: 3.078

3.  Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and β-amyloid pathology.

Authors:  Eva Alonso; Carmen Vale; Mercedes R Vieytes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-04-08       Impact factor: 4.418

Review 4.  Targets and effects of yessotoxin, okadaic acid and palytoxin: a differential review.

Authors:  Antonella Franchini; Davide Malagoli; Enzo Ottaviani
Journal:  Mar Drugs       Date:  2010-03-16       Impact factor: 5.118

5.  Mitotic Catastrophe in BC3H1 Cells following Yessotoxin Exposure.

Authors:  Mónica Suárez Korsnes; Reinert Korsnes
Journal:  Front Cell Dev Biol       Date:  2017-03-31

Review 6.  Biotechnological and Pharmacological Applications of Biotoxins and Other Bioactive Molecules from Dinoflagellates.

Authors:  Joana Assunção; A Catarina Guedes; F Xavier Malcata
Journal:  Mar Drugs       Date:  2017-12-20       Impact factor: 5.118

Review 7.  Yessotoxins, a group of marine polyether toxins: an overview.

Authors:  Beatriz Paz; Antonio H Daranas; Manuel Norte; Pilar Riobó; José M Franco; José J Fernández
Journal:  Mar Drugs       Date:  2008-05-07       Impact factor: 5.118

Review 8.  Yessotoxin, a Promising Therapeutic Tool.

Authors:  Amparo Alfonso; Mercedes R Vieytes; Luis M Botana
Journal:  Mar Drugs       Date:  2016-01-28       Impact factor: 5.118

9.  Lifetime Distributions from Tracking Individual BC3H1 Cells Subjected to Yessotoxin.

Authors:  Mónica Suárez Korsnes; Reinert Korsnes
Journal:  Front Bioeng Biotechnol       Date:  2015-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.